Cryopreservation as Optimizing Factor in Therapeutic Effect of Products of Embryofetoplacental Complex (PEFPC) Part 1. Pathology of autoimmune genesis as assessment model of therapeutic effect of PEFPC application

Authors

  • A. N. Goltsev Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkov
  • K. N. Popova Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkov
  • M. A. Sirous Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkov

Keywords:

autoimmune diseases, autoimmune hemolytic anemia, ethyopathogenesis, lymphohemopoietic complex, products of embryofetoplacental complex, cryopreservation

Abstract

The possibility of using model autoimmune diseases for estimating a therapeutic efficiency of cryopreserved products of embryofetoplacental complex (PEFPC) is substantiated. With the example of autoimmune hemolytical anemia there has been shown a multi-profile change of the state of lymphohemopoietic complex of the animals with this pathology. The changes in various links of immune system during pathology development are emphasized. There is noted a possible dependence of their manifestation extent on disorder of harmonic interaction in neuroimmune endocrine block of an organism that stipulates the necessity of treatment of such diseases by preparations with a polyfunctional orientation effect, namely PEFPC.

Downloads

Published

2006-09-15

How to Cite

Goltsev, A. N., Popova, K. N., & Sirous, M. A. (2006). Cryopreservation as Optimizing Factor in Therapeutic Effect of Products of Embryofetoplacental Complex (PEFPC) Part 1. Pathology of autoimmune genesis as assessment model of therapeutic effect of PEFPC application. Problems of Cryobiology and Cryomedicine, 16(3), 326–340. Retrieved from http://cryo.org.ua/journal/index.php/probl-cryobiol-cryomed/article/view/588

Issue

Section

Cryomedicine, Clinical and Experimental Transplantology